Project Grant HT94252410639
Award Date
9/1/24
Completion Date
8/31/28
Dollars Obligated
$4.2M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Minneapolis, MN 55455, USA
Similar Awards
This federal Project Grant award, valued at $1,618,500.00 and awarded by the Defense Health Agency, is funding research at the Regents of the University of Minnesota under the Military Medical Research and Development (CFDA 12.420) program. The project, titled "TARGETING EIF4F COMPLEX-DRIVEN TRANSLATION OF ONCOGENIC MRNAS IN CRPC", aims to investigate innovative approaches to cancer research and treatment, with a particular focus on prostate cancer. As a prominent land-grant research...
This federal Project Grant award from the Department of the Army Medical Command (CFDA 12.420 - Military Medical Research and Development) provides $1,348,041.00 to the Regents of the University of Minnesota to develop a RET-specific proteomic assay from circulating tumor cells in lethal prostate cancer. The award began on Mar 1, 2024 and is scheduled for completion by Feb 28, 2027. This research aims to transform health care for military service members and the general public through innovative...
This $1,539,818.00 Department of the Army Medical Command federal Project Grant award under the Military Medical Research and Development program (CFDA 12.420) will fund research led by the Regents of the University of Minnesota to develop multiplex edited, dual CAR gamma delta T cells targeting pediatric solid tumors. The three-year project, with a performance period from November 15, 2024 to November 14, 2027, seeks to advance innovative cell-based immunotherapies for the treatment of...
This federal Project Grant award from the Department of the Army Materiel Command Research Development and Engineering Command under CFDA 12.431 "Basic Scientific Research" provides $157,648.00 in funding to the Regents of the University of Minnesota to conduct foundational and applied research across scientific domains critical to national security. The award, with a performance period from July 1, 2024 to June 30, 2027, will support the university's multidisciplinary research...
The University of Minnesota, through its Office of Sponsored Projects Administration, was awarded a $1,521,386 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to engage the immune system to kill sarcoma through a comparative oncology approach. The 3-year grant, which began on July 15, 2023 and will be completed by July 14, 2026, supports basic, applied, and advanced biomedical research to transform healthcare for service...
This $1,848,000.00 federal Project Grant award under the Military Medical Research and Development program (CFDA 12.420), administered by the Defense Health Agency, supports the University of Minnesota's research on "Therapeutic Targeting of Aberrant mRNA Polyadenylation in Lethal Prostate Cancer." The project aims to investigate innovative approaches to disease prevention, diagnosis, treatment, and management of prostate cancer, with a focus on conditions relevant to military...
The Regents of the University of Minnesota, through its Office of Sponsored Projects Administration, was awarded a $331,846 Project Grant by the Department of the Army Materiel Command Research Development and Engineering Command. The grant is funded under the Basic Scientific Research program (CFDA 12.431), which supports basic research related to or having potential to improve Army programs or operations. Under this 1-year grant awarded on September 1, 2023, the University of Minnesota will...
The Regents of the University of Minnesota was awarded a $1,202,776 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from July 1, 2023 to June 30, 2027 to map elements of DNA architecture responsible for malignant transformation in craniospinal sarcoma. Through this award, the University of Minnesota will conduct biomedical research to identify medical solutions for battlefield...
The Regents of the University of Minnesota received a three-year, $532,038 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research into estrogen-driven tumorigenesis in invasive lobular carcinoma from July 15, 2022 to July 14, 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program provides $1,155,000.00 to the Regents of the University of Minnesota to conduct research evaluating natural killer cell function in prostate cancer patients across racial backgrounds. The goal is to address any functional disparities using trispecific killer engagers. The award has a performance period from June 1, 2025 to May 31, 2029. As a...